Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for Biofrontera Inc have a median target of 11.50, with a high estimate of 16.00 and a low estimate of 7.00. The median estimate represents a 791.47% increase from the last price of 1.29.
High | 1,140.3% | 16.00 |
Med | 791.5% | 11.50 |
Low | 442.6% | 7.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 09, 2024.
Average growth rate | +67.04% |
Average growth rate | -985.53% |
More ▼
Revenue history & estimates in USD
Average growth rate | +11.24% |
Average growth rate | +18.90% |
More ▼